![](/img/cover-not-exists.png)
Meta-analysis of the risks of hypertension and QTc prolongation in patients with advanced non-small cell lung cancer who were receiving vandetanib
Liu, Ying, Liu, Yi, Fan, Zai-Wen, Li, Jian, Xu, Guo-GangVolume:
71
Language:
english
Journal:
European Journal of Clinical Pharmacology
DOI:
10.1007/s00228-015-1831-1
Date:
May, 2015
File:
PDF, 492 KB
english, 2015